SR-B1-Mediated Transplacental Transfer of Hydrophobic Toxicants Disrupts Fetal Development During Barriergenesis

Yixuan Huang1, Hailin Shang1, Ling Jiao1

  • 1Laboratory For Earth Surface Processes, College of Urban and Environmental Sciences, Peking University, Beijing, China.

Gestation represents a critical developmental window of fetal vulnerability to xenobiotic-induced disruptions of biological homeostasis. While xenobiotic transfer is primarily studied through maternal-fetal comparisons at delivery, its spatiotemporal distribution across gestation stages, particularly the transport mechanisms in early pregnancy, remains poorly understood. In this study, we reveal spatiotemporal heterogeneity of hydrophobic toxicants (including persistent organic pollutants such as medium-chain chlorinated paraffins [MCCPs] and hexabromocyclododecane) and endogenous metabolites in the developing placenta and fetus by mass spectrometry imaging (MSI). The stage of transition to hemotrophic nutrition is found as a critical window with fetal-to-maternal distribution ratios of xenobiotics approximately 8.4-38.2-times higher than those estimated at birth. At this critical stage, Scavenger Receptor Class B Member 1 (SR-B1) is identified as the key, stage-specific, and predominate transporter mediating fetal delivery of hydrophobic toxicants and lipids in early gestation through integration of spatial metabolomics and single-nucleus RNA sequencing of placental tissue. Finally, our findings demonstrate that early gestational exposure to MCCPs is associated with fetal neuro-lipotoxicity. The results highlight the urgent need to reduce early-pregnancy xenobiotic exposure for preventing toxicant-associated fetal lipid metabolic disruption.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.3K
Physiological Barriers01:25

Physiological Barriers

Physiological barriers are semi-permeable cellular structures restricting drug diffusion into intracellular compartments and tissues. There are six types of physiological barriers: blood endothelial, cell membrane, blood-brain, blood-cerebrospinal fluid (CSF), blood-placenta, and blood-testis barriers.
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
5.4K
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
4.3K
Factors Affecting Drug Distribution: Physiological Barriers01:23

Factors Affecting Drug Distribution: Physiological Barriers

Drug distribution in the body is intricately regulated by various physiological barriers that control the passage of substances. These include the capillary endothelial barrier, the blood-brain, blood-cerebrospinal fluid, blood-placental, and blood-testis barriers.
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
831
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
3.6K